Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1960 2
1961 6
1962 7
1963 9
1964 5
1965 8
1966 14
1967 13
1968 18
1969 21
1970 17
1971 23
1972 8
1973 33
1974 23
1975 27
1976 28
1977 32
1978 29
1979 37
1980 43
1981 39
1982 35
1983 52
1984 68
1985 76
1986 68
1987 71
1988 97
1989 91
1990 74
1991 86
1992 101
1993 110
1994 120
1995 104
1996 106
1997 97
1998 121
1999 150
2000 146
2001 160
2002 175
2003 174
2004 209
2005 215
2006 228
2007 233
2008 221
2009 224
2010 216
2011 244
2012 264
2013 266
2014 263
2015 268
2016 281
2017 344
2018 348
2019 305
2020 362
2021 375
2022 354
2023 330
2024 284
2025 346
2026 272

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,284 results

Results by year

Filters applied: . Clear all
Page 1
2025 focused update of the 2020 ISTH guidelines for management of thrombotic thrombocytopenic purpura.
Zheng XL, Al-Housni Z, Cataland SR, Coppo P, Geldziler B, Germini F, Iorio A, Keepanasseril A, Masias C, Matsumoto M, McCrae KR, McIntyre J, Mustafa RA, Peyvandi F, Russell L, Tarawneh R, Vesely SK; International Society on Thrombosis and Haemostasis. Zheng XL, et al. Among authors: matsumoto m. J Thromb Haemost. 2025 Nov;23(11):3711-3732. doi: 10.1016/j.jtha.2025.06.002. Epub 2025 Jun 17. J Thromb Haemost. 2025. PMID: 40533296 Free PMC article.
Thrombotic thrombocytopenic purpura: early diagnosis and effective treatment in 2025.
Azoulay E, Veyradier A, Cataland S, Joly BS, Knoebl P, Zafrani L, Wendon J, Fakhouri F, Lämmle B, Pavenski K, Biebuyck N, Vanhoorelbeke K, Chaturvedi S, Pishko AM, Donadello K, Scully M, Matsumoto M, Peyvandi F, Mingot-Castellano ME, Zheng XL, Mariotte E, Benhamou Y, Coppo P. Azoulay E, et al. Among authors: matsumoto m. Intensive Care Med. 2025 Jul;51(7):1225-1239. doi: 10.1007/s00134-025-07981-3. Epub 2025 Jul 3. Intensive Care Med. 2025. PMID: 40608084 Review.
Daratumumab plus VRd in Japanese transplant-ineligible/deferred NDMM patients: Japanese subgroup of the CEPHEUS trial.
Suzuki K, Matsumoto M, Takamatsu H, Kosugi H, Kondo T, Fujisaki T, Facon T, Zweegman S, Ito M, Sakai C, Kanai S, Nakatogawa T, Rowe M, Carson R, Usmani SZ. Suzuki K, et al. Among authors: matsumoto m. Int J Hematol. 2026 Jul;124(1):104-113. doi: 10.1007/s12185-026-04185-3. Epub 2026 Mar 27. Int J Hematol. 2026. PMID: 41894094 Free PMC article. Clinical Trial.
Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project).
Coppo P, Bubenheim M, Benhamou Y, Völker L, Brinkkötter P, Kühne L, Knöbl P, Mingot-Castellano ME, Pascual-Izquierdo C, de la Rubia J, Del Rio Garma J, Chaturvedi S, Masias C, Mazepa M, Zheng XL, Sinkovits G, Réti M, Patriquin CJ, Pavenski K, Boechat T, Farias J, Oliveira Ribeiro EF, Lobo de Andrade ML, Veyradier A, Joly B, Bouzid R, Sakai K, Matsumoto M, Agosti P, Mancini I, Peyvandi F, Gavriilaki E, Stubbs M, Hmaid A, Cataland S, Lämmle B, Scully M. Coppo P, et al. Among authors: matsumoto m. EClinicalMedicine. 2025 Mar 30;82:103168. doi: 10.1016/j.eclinm.2025.103168. eCollection 2025 Apr. EClinicalMedicine. 2025. PMID: 40235949 Free PMC article.
Lubiprostone in chronic kidney disease: Insights into mitochondrial function and polyamines from a randomized phase 2 clinical trial.
Watanabe S, Nakayama M, Yokoo T, Sanada S, Ubara Y, Komatsuda A, Asanuma K, Suzuki Y, Konta T, Kazama JJ, Suzuki T, Fukuda S, Soga T, Yamada T, Mizutani S, Matsumoto M, Naito Y, Taguchi K, Fukami K, Kashiwagi H, Kikuchi K, Suzuki C, Tokuno H, Urasato M, Kujirai R, Matsumoto Y, Akiyama Y, Tomioka Y, Itai S, Tongu Y, Mishima E, Kawabe C, Kasahara T, Ogata Y, Toyohara T, Sato T, Tanaka T, Abe T; LUBI-CKD TRIAL Investigators. Watanabe S, et al. Among authors: matsumoto m. Sci Adv. 2025 Aug 29;11(35):eadw3934. doi: 10.1126/sciadv.adw3934. Epub 2025 Aug 29. Sci Adv. 2025. PMID: 40880481 Free PMC article. Clinical Trial.
Prostate-specific Antigen Decline During Primary Androgen-deprivation Therapy for Predicting Response and Survival in Metastatic Castration-resistant Prostate Cancer Patients Receiving Enzalutamide.
Nagata Y, Sugi T, Yamamura S, Sugita Y, Mizushima Y, Matsukawa T, Takaba T, Jojima K, Higashijima K, Matsumoto M, Minato A, Tomisaki I, Kashiwagi E, Fujimoto N. Nagata Y, et al. Among authors: matsumoto m. In Vivo. 2025 Jul-Aug;39(4):2209-2218. doi: 10.21873/invivo.14016. In Vivo. 2025. PMID: 40579003 Free PMC article.
SOX10 Regulates Melanoma Metastasis Through the IRF1-ITGA3/EphA2-FAK Pathway.
Kaminaka R, Takahashi N, Nishizawa M, Sasaki S, Sugihara Y, Matsumoto M, Taniguchi R, Zhou Y, Hayakawa Y, Sakurai H, Yokoyama S. Kaminaka R, et al. Among authors: matsumoto m. Cancer Sci. 2025 Nov;116(11):3052-3065. doi: 10.1111/cas.70173. Epub 2025 Aug 13. Cancer Sci. 2025. PMID: 40808260 Free PMC article.
eIF2D promotes 40S ribosomal subunit recycling during intrinsic ribosome destabilization.
Ichihara K, Shiraishi T, Chadani Y, Kito Y, Shiraishi C, Hirata M, Takahashi Y, Kobo A, Hatano A, Matsumoto M, Machida K, Imataka H, Toyoda A, Mishiro-Sato E, Nojima T, Ito T, Taguchi H, Nakayama KI, Matsumoto A. Ichihara K, et al. Among authors: matsumoto m. Nucleic Acids Res. 2025 Nov 26;53(22):gkaf1322. doi: 10.1093/nar/gkaf1322. Nucleic Acids Res. 2025. PMID: 41335470 Free PMC article.
8,284 results